Spain – Various medicinal products – Suministro del medicamento Remsima 120mg, solución inyectable en pluma precargada,
Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria awarded €561K to KERN PHARMA, S.L. for Construction & Public Works in November 2024 — one of 94 awards this buyer has made, above its typical award size.
Winning supplier
KERN PHARMA, S.L.Contract description
Spain – Various medicinal products – Suministro del medicamento Remsima 120mg, solución inyectable en pluma precargada, (principio activo Infliximab), de cuantía indeterminada (Disposición adicional 33 Ley 9/2017, de Contratos del sector público), mediante procedimiento negociado sin publicidad.
Related awards · Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria
94 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-354025-2025WERFEN ESPAÑA, S.A.U.€652K02 Jun 2025 Construction
- ocds-ted-693178-2024Roche Farma, S.A.€553K14 Nov 2024 Construction
- ocds-ted-526230-2025UCB PHARMA,S.A€500K12 Aug 2025 Construction
Other wins · KERN PHARMA, S.L.
37 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-149649-2026-4Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar€5.1M04 Mar 2026 Construction
- ocds-ted-424178-2024OSAKIDETZA - Servicio Vasco de Salud - Organización Central€1.4M16 Jul 2024 Construction
- ocds-ted-181195-2025-4Fundación de Gestión Sanitaria del Hospital de la Santa Creu i Sant Pau€514K20 Mar 2025 Construction
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria and KERN PHARMA, S.L. — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back